|Bank/Broker||Analyst||Rating||Price target (EUR)
|goetzpartners, London||Martin Brunninger||Neutral||6.82||26 September 2017|
|First Berlin Equity Research GmbH||Simon Scholes||Buy||7.30||06 October 2017|
|equinet Bank AG||Marietta Miemietz||Accumulate||4.72||21 September 2017|
Epigenomics AG is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Epigenomics’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Epigenomics or its management. Epigenomics does not, by its reference below or distribution, imply its endorsement of or concurrence with such information, conclusions or recommendations.